Chiesi Group · 2 months ago
Lead Finance Business Partner, AIR, US
Chiesi Farmaceutici is an international biopharmaceutical group focused on sustainable innovation and promoting a healthier world. They are seeking a Lead Finance Business Partner to provide financial insights and analysis, partner with senior leadership, and oversee budgeting and forecasting processes within the Respiratory business unit.
BiotechnologyMedicalPharmaceutical
Responsibilities
Partner with senior leadership to develop and execute financial strategies aligned with business goals
Compile business case proposals, including the related financial analyses to support assessment of business opportunities and risks
Develop accurate and organized full P&L financial models based on agreed upon assumptions, including scenario analyses
Present business case scenarios to local and global senior leadership as needed
Identify opportunities to invest, elicit cost savings, and mitigate risks within the business unit and communicate them to the appropriate leaders
Act as liaison in analyzing and communicating with third party alliance representatives
Partner with global finance and global BU teams on various projects and reporting needs
Establish and execute the monthly financial review process for business units, analyzing material financial variances vs plan and expected full-year impacts
In conjunction with the Head of FP&A, oversee budgeting and forecasting processes for the BU to ensure appropriate allocation of resources to achieve strategic objectives
Design and implement KPIs/analytics to be used in communicating performance
Ensure integrity of BU financials by establishing and reinforcing processes to ensure financial accuracy
Translate financial data into actionable insights, manage budgets and forecasts, and analyze performance to recommend improvements
Understand FP&A system capabilities in order to coordinate process improvement/innovation
Advise colleagues regarding financial processes & systems
Reinforce reporting system and report governance
Prepare ad-hoc reports, financial models, and process documentation as needed to support senior management and various department requests
Qualification
Required
Finance or Accounting degree
Minimum 8–10 years of progressive experience in finance roles, with at least 3 years in a business partnering capacity
Prior experience in the pharmaceutical, biotech, or life sciences sector
Prior experience presenting business cases and financial models to senior leadership
Proven track record of influencing senior stakeholders and driving business performance
Strong analytical and quantitative thinking paired with Excel modelling skills and high level of accuracy and attention to detail
Ability to challenge performance, drive fact-based business decisions, learning and solution-oriented enterprise mindset
Excellent business acumen, ability to see the big picture and understand all relevant details
Ability to multitask, respond successfully under pressure, effectively prioritize, and manage time and workload to meet business needs
Ability to act and operate independently to accomplish objectives
Advanced skill in MS Office Excel & PowerPoint
Experience with reporting systems
Aptitude to learn computer applications as needed
Demonstrated proficiency in written, verbal and face-to-face communication to effectively present information to and influence decision making of working and business partners (local and global), internal customers, and other stakeholders
Preferred
Masters of Accounting/MBA
Certified Public Accountant (CPA)
Knowledge of Board and Tagetik a plus
Benefits
Comprehensive healthcare programs
Work-life balance initiatives
Robust relocation support
Flexible working arrangements
Remote work options
Tax assistance services for foreign colleagues
Company
Chiesi Group
Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care.
Funding
Current Stage
Late StageLeadership Team
Recent News
2026-01-22
2026-01-13
Company data provided by crunchbase